Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

INSULIN-LIKE GROWTH FACTOR I - ANVISA Registration 80102513174

Access comprehensive regulatory information for INSULIN-LIKE GROWTH FACTOR I in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80102513174 and manufactured by SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.. The registration is held by VR MEDICAL IMPORTADORA E DISTRIBUIDORA DE PRODUTOS MÉDICOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS LIMITED, IMMUNODIAGNOSTICS SYSTEM LTD, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
80102513174
Registration Details
ANVISA Registration Number: 80102513174
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

Família MAGLUMI IGF-1 (CLIA)
Risk Class II

Registration Details

80102513174

25351803375202370

04718143000194

Company Information

China
PT: CHINA, REPÚBLICA POPULAR

Dates and Status

Jan 02, 2024

VIGENTE

09/18/2025 19:00:01